ATE233745T1 - Arzneistoffe - Google Patents
ArzneistoffeInfo
- Publication number
- ATE233745T1 ATE233745T1 AT96945283T AT96945283T ATE233745T1 AT E233745 T1 ATE233745 T1 AT E233745T1 AT 96945283 T AT96945283 T AT 96945283T AT 96945283 T AT96945283 T AT 96945283T AT E233745 T1 ATE233745 T1 AT E233745T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal substances
- cryptophycin compounds
- novel cryptophycin
- disrupting
- administering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US914595P | 1995-12-22 | 1995-12-22 | |
US2507996P | 1996-08-30 | 1996-08-30 | |
PCT/US1996/020633 WO1997023211A1 (en) | 1995-12-22 | 1996-12-20 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE233745T1 true ATE233745T1 (de) | 2003-03-15 |
Family
ID=26679113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96945283T ATE233745T1 (de) | 1995-12-22 | 1996-12-20 | Arzneistoffe |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0869786B1 (de) |
JP (1) | JP2000502351A (de) |
AT (1) | ATE233745T1 (de) |
AU (1) | AU1469097A (de) |
CA (1) | CA2241086A1 (de) |
DE (1) | DE69626544T2 (de) |
ES (1) | ES2194129T3 (de) |
WO (1) | WO1997023211A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6680311B1 (en) | 1996-08-30 | 2004-01-20 | Eli Lilly And Company | Cryptophycin compounds |
CA2264063C (en) * | 1996-08-30 | 2007-03-13 | Eli Lilly And Company | Cryptophycin compounds |
JP2001500128A (ja) * | 1996-09-06 | 2001-01-09 | イーライ・リリー・アンド・カンパニー | 薬用組成物を製造する方法 |
AU6338698A (en) * | 1997-02-26 | 1998-09-18 | Eli Lilly And Company | Tripeptide and tetrapeptide pharmaceutical compounds |
CA2281104A1 (en) * | 1997-02-26 | 1998-09-03 | University Of Hawaii | Selective epoxidation process for preparing pharmaceutical compounds |
EP0870506A1 (de) * | 1997-04-11 | 1998-10-14 | Eli Lilly And Company | Zusammentsetzungen enthaltend ein Cryptophycin Derivat in Kombination mit einem synchronisierten Wirkstoff oder Aktivierungsmittel zur Behandlung von Krebs |
US6376230B1 (en) | 1998-10-16 | 2002-04-23 | Eli Lilly And Company | Stereoselective process for producing intermediates of cryptophycins |
US6103913A (en) * | 1998-10-16 | 2000-08-15 | Eli Lilly And Company | Process for preparing enollactone derivatives |
CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116954A (en) * | 1988-04-06 | 1992-05-26 | Lipha, Lyonnaise Industrielle Pharmaceutique | Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety |
GB8814813D0 (en) * | 1988-06-22 | 1988-07-27 | Beecham Group Plc | Novel compounds |
US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
DE69427706T2 (de) * | 1993-12-21 | 2001-10-25 | University Of Hawaii, Honolulu | Cryptophycine |
WO1997008334A1 (en) * | 1995-08-30 | 1997-03-06 | University Of Hawaii | Cryptophycins from aberrant biosynthesis |
WO1998008506A1 (en) * | 1996-08-30 | 1998-03-05 | Eli Lilly And Company | Pharmaceutical compounds |
EP0923564A4 (de) * | 1996-08-30 | 1999-12-08 | Lilly Co Eli | Pharmazeutische verbindungen |
-
1996
- 1996-12-20 AU AU14690/97A patent/AU1469097A/en not_active Abandoned
- 1996-12-20 EP EP96945283A patent/EP0869786B1/de not_active Expired - Lifetime
- 1996-12-20 ES ES96945283T patent/ES2194129T3/es not_active Expired - Lifetime
- 1996-12-20 WO PCT/US1996/020633 patent/WO1997023211A1/en active IP Right Grant
- 1996-12-20 JP JP09523866A patent/JP2000502351A/ja active Pending
- 1996-12-20 DE DE69626544T patent/DE69626544T2/de not_active Expired - Fee Related
- 1996-12-20 AT AT96945283T patent/ATE233745T1/de not_active IP Right Cessation
- 1996-12-20 CA CA002241086A patent/CA2241086A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU1469097A (en) | 1997-07-17 |
JP2000502351A (ja) | 2000-02-29 |
WO1997023211A1 (en) | 1997-07-03 |
EP0869786A1 (de) | 1998-10-14 |
EP0869786B1 (de) | 2003-03-05 |
DE69626544T2 (de) | 2004-01-15 |
ES2194129T3 (es) | 2003-11-16 |
DE69626544D1 (de) | 2003-04-10 |
EP0869786A4 (de) | 1999-04-14 |
CA2241086A1 (en) | 1997-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT934065E (pt) | Compostos farmaceuticos | |
ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
DE69812159D1 (de) | Derivate des adamantan | |
NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
DE602004027936D1 (de) | Tocopherolmodifizierte therapeutische arzneimittelverbindung | |
ES2114487B1 (es) | Mezcla estabilizante sinergistica. | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
TR199700711T1 (xx) | Ciltten ge�erek v�cuda giren form�lasyon. | |
ATE233745T1 (de) | Arzneistoffe | |
DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
GB9907571D0 (en) | Compounds | |
ATE208200T1 (de) | Transdermales therapeutisches system (tts) zur verabreichung von testosteron | |
HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
SE0004827D0 (sv) | Therapeutic compounds | |
MX9801604A (es) | Compuestos farmaceuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |